Aug 28, 2026 | Breast cancer, Cancer, Claims, Colon Cancer, Heart disease, High-cost claims, MedBen WellLiving
Tokio Marine HCC’s 2026 Annual Market Report underscores two persistent drivers of high-cost claims. In 2025, cancers accounted for 35.2% of total costs and cardiovascular diseases another 12.7% — nearly 48% combined, far more than any other diagnostic categories....
Jul 17, 2026 | At-home colon cancer tests, Cancer, Colon Cancer, Colonoscopy, MedBen WellLiving, Wellness, Wellness screenings
The American Cancer Society has expanded colorectal cancer screening guidelines to include a new blood test and additional at-home stool options. The aim is greater accessibility, especially for those who might otherwise skip screening. However, the guidelines still...
Jun 17, 2026 | Cancer, Colon Cancer, Family doctors, Family health history, Preventive Care, Primary Care, Wellness
Knowing your family’s health history — and making sure your primary care physician knows it too — can make a real difference in catching serious conditions early. KFF Health News recently shared the story of a 33-year-old woman who discovered only after being...
Aug 22, 2025 | Cancer, Colon Cancer, Colonoscopy, MedBen WellLiving, Preventive Care, Primary Care, Research, Wellness screenings
New research from the American Cancer Society highlights the life-saving and cost-saving value of early colon cancer detection – a priority in MedBen WellLiving’s proactive wellness approach. Screenings for U.S. adults aged 45 to 49 rose 62% from 2019 to 2023,...
Mar 7, 2025 | At-home colon cancer tests, Cancer, Colon Cancer, Colonoscopy, MedBen WellLiving, Wellness
At-home colon cancer screening tests have grown increasingly popular due to their convenience and non-invasiveness. However, colonoscopies remain the gold standard for colon cancer screening – which is why MedBen WellLiving programs typically recommend them every...
Aug 2, 2024 | Cancer, Colon Cancer, Colonoscopy, Food and Drug Administration (FDA), News, Preventive Care, Research, Wellness
On July 29, the Food and Drug Administration approved a first-of-its-kind blood test determined to be 83% effective at detecting colon cancer. Called Shield, the noninvasive test was authorized for use by people aged 45 and older with an “average risk” of the...
